In September 2019, Four Day Ray Brewing announced its partnership with Brewing Funds the Cure (BFTC) with the release of Rising Hope IPA. 100% of the proceeds from this beer went back to the National Pediatric Cancer Foundation (NPCF). Over the course of 11 weeks, and with your help, we were able to donate $17,500 to help save the lives of children battling cancer. This donation alone will go into funding nearly 300 hours of research time for doctors and scientists working on the Sunshine Project! We could not have done this without the support from our community.
The National Pediatric Cancer Foundation is a nonprofit organization dedicated to funding research to eliminate childhood cancer through the Sunshine Project, the Foundation’s collaborative research initiative. By partnering with doctors and researchers from the country’s top institutions, the Sunshine Project is fast-tracking the development of new drugs and therapies that will ultimately lead to the cure of childhood cancers. They have invested over $23 million in research to reduce the side effects of current therapies, improve survival rates, and ultimately eliminate childhood cancer. The NPCF has received a perfect 100% score for financial health and transparency and is recognized as the top-rated cancer charity in the U.S. by Charity Navigator. For more information, visit www.NationalPCF.org
In year 1 of Rising Hope being spread across the country, they expect over $130,000 will be raised from their partner breweries combined! Because of programs such as Brewing Funds the Cure and the Rising Hope IPA Release, The National Pediatric Cancer Foundation is committed and able to continue cutting-edge research for children battling cancer.
2020 NPCF Clinical Trials & Research Projects:
Brain Tumor Trial: Researchers use a portion of the patient’s brain tumor and their immune system to create a vaccine to stimulate the patient’s immune system to fight off the brain tumor cells.
LSD1 Inhibitor Trial for Relapsed Ewing Sarcoma: First in a human trial using a newly developed drug that is designed to block the part of a patient’s DNA that plays a role in cancer cell growth.
Osteosarcoma Trial: Trial with the goal of enhancing the effectiveness of immunotherapy treatment by combing it with an agent that prevents cancer cells from reproducing or growing.
Diagnostic Blood-Based Biomarker Trial: A cutting edge blood test that looks at the number of cancer cells in the blood. This trial has the potential of making an immediate impact on how we treat sarcomas.
Rhabdomyosarcoma Trial: Trial for newly diagnosed, metastatic, fusion-positive rhabdomyosarcoma patients that are using treatment approaches inspired by evolution.
For more information about Brewing Funds the Cure and to locate other brewery partners involved in the Rising Hope project visit: https://nationalpcf.org/brewing-funds-the-cure/rising-hope/